Page last updated: 2024-09-04

tipifarnib and Osteosarcoma

tipifarnib has been researched along with Osteosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Geryk-Hall, M; Hughes, DP; Yang, Y	1

Other Studies

1 other study(ies) available for tipifarnib and Osteosarcoma

Article	Year
Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected]. Molecular cancer therapeutics, 2010, Volume: 9, Issue:5 Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Male; Osteosarcoma; Quinolones; ras Proteins; U937 Cells; Up-Regulation	2010

Article

Year

Driven to death: Inhibition of farnesylation increases Ras activity and promotes growth arrest and cell death [corrected].

Molecular cancer therapeutics, 2010, Volume: 9, Issue:5

Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Evaluation, Preclinical; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Male; Osteosarcoma; Quinolones; ras Proteins; U937 Cells; Up-Regulation

2010